DOI:
10.1055/s-00043364
Pharmaceutical Fronts
LinksClose Window
References
Kavarthapu R, Anbazhagan R, Dufau ML.
Crosstalk between PRLR and EGFR/HER2 Signaling Pathways in Breast Cancer.
Cancers (Basel) 2021;
13 (18) 4685
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.